Description

Key Features & Benefits

• Exceptional Bioavailability: Up to 69% absorption of iron in the human body.
• Slow-Release Formulation: Gradual iron release from the gastrointestinal tract to minimize irritation and enhance tolerability.
• Reduced Toxicity & Side Effects: Lower risks from free iron and fewer gastrointestinal adverse events.
• Extended Intervention Window in Overdose: Significantly reduced risk in accidental excessive intake.
• Not Inhibited by Hepcidin: Maintains effective absorption even under inflammatory conditions or increased physiological demand.

Scientific Advantages of Reolin™ (Fe⁰)

Five exclusive patented features:

1. Optimized Particle Size: 8.5 µm — specifically designed for maximum uptake via DMT1 and TFR1 receptors in the duodenum.
   
2. Spherical Particle Geometry: Enhances flowability and uniform distribution throughout the GI tract.
3. Uniform Particle Dimensions: Stable absorption and predictable release profile.
4. Smooth, Polished Surface: Reduces mucosal irritation and optimizes contact with absorptive surfaces.
5. Slow‑Release with 69% Bioavailability: Increases efficiency and minimizes accumulation of unusable iron.

Medical Indications of Reol®

(Elemental Reolin™ Iron — Slow Release, High Safety Margin)

• Prevention and treatment of iron-deficiency anemia in all age groups.
• Pregnant & Lactating Women: Meets WHO daily iron requirement for maternal and fetal health
• Gastrointestinal disorders: suitable and well tolerated even in patients with IBS due to minimal constipation
• Children & Adolescents: Ideal for long-term maintenance dosage.3
• Iron deficiency associated with blood loss or chronic diseases (e.g., chronic kidney disease, inflammatory disorders, hematologic conditions).
• High-demand situations: rapid growth, adolescence, intensive sports, or medically increased iron demands.
• Nutritional support in poor absorption states: chronic GI diseases (ulcerative colitis, Crohn’s disease), GI cancers, and post‑gastrectomy/resection patients.

High Safety for Long‑Term Use

• Slow‑release prevents sudden peaks in free iron concentration.
• LD₅₀ = 50,000 mg — extremely high safety margin, suitable for pediatric and elderly use.
• Minimal unabsorbed iron in the intestine — reduces overdose risk and free iron accumulation.
• No increased risk of sepsis: Gradual release avoids promoting pathogenic bacterial growth, lowering systemic infection risk.
• Appropriate for vulnerable groups: children, pregnant women, elderly patients, chronically ill individuals, and immunocompromised persons.

Reol® 27 – Specifically Tailored for Pregnancy and Special Life Stages

Reol® 27 mg is precisely formulated to meet the World Health Organization’s recommended daily iron intake for pregnant women. Each tablet contains 27 mg elemental Reolin™ iron (Fe⁰) — ideal for conditions with elevated iron requirements.

Scientific & Clinical Benefits of Reol® 27

1. Patented Reolin™ Formulation: Optimized particle size (8.5 µm) and complete uniformity deliver 69% bioavailability with gradual GI release.
   
2. Superior Tolerability: No metallic taste, minimal GI discomfort, markedly reduced constipation and bloating compared to iron salts.
3. Not inhibited by Hepcidin: Effective absorption in inflammatory or chronic diseases.
4. Compact, Easy-to-Swallow Tablet: Enhanced patient compliance, even among elderly or patients with swallowing difficulties.
5. Designed for Pregnancy:
   • One tablet daily meets WHO iron requirement.
   • Does not cause bloating, heartburn, or trigger nausea/gag reflex.

Indications for Reol® 27

• Iron supplementation during pregnancy (primary indication)
• Iron-deficiency anemia with high daily requirements
• Postpartum iron replenishment
• Support in heavy menstrual bleeding

Safety Profile

• LD₅₀ = 50,000 mg — extremely high margin of safety
• GRAS FDA-certified source material
• Minimal residual intestinal iron — reduced overdose risk
• Safe for long-term use across all age groups

Description

Reol ®

Reol ® contains Reolin elemental iron , which :

• has a high iron content exceeding 98%
• has very high level bioavailability
• has a safety certificate of GRAS (Generally recognized as safe )

Reol ® tablet is intended for Adults

• does not cause stomach ache , vomiting diarrhea and constipation
• does not distrub the intestinal microflora
• no metallic aftertaste

Active ingredients :

• Each tablet contains 18mg Reolin
• Elemental iron

Recommended dosage :

• take 1 tablet daily